Dana-Farber Cancer Institute

Continuing Professional Education

    In this section

    Advancing Cancer Education for Healthcare Professionals

    At Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, we are committed to equipping healthcare professionals with the latest advances in cancer research, treatment, and care through continuing professional education.

    As part of that commitment, Dana-Farber has begun the process of seeking accreditation from the Accreditation Council for Continuing Medical Education (ACCME). A decision is anticipated in Summer 2026, with the first ACCME-accredited activity planned to launch in Fall 2026. 

    Pursuing ACCME accreditation represents an important step in expanding access to trusted, high-quality, evidence-based educational opportunities for clinicians and other professionals involved in cancer care.

    Stay Informed

    If you are a medical professional interested in participating in future Dana-Farber-accredited educational programs, we invite you to join our email list.

    Join the Email List

    Current Education Opportunities

    Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches

    Runs: September 14, 2026
    Course format: Live Online or In-Person

    Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.

    View course and register

    Training our Eyes, Minds and Hearts: Visual Thinking Strategies for Health Care Professionals

    Runs: October 7, 2026 – March 10, 2027
    Course format: Online in real time

    Acquire transformative, evidence-based tools for enhancing patient care, teamwork, and personal well-being in this immersive, accredited course.

    View course and register

    Stem Cell Transplant and Cellular Therapies Symposium 2026: Navigating a Rapidly Changing Landscape

    Runs: October 16, 2026
    Course format: In-Person at 450 Brookline Avenue, Boston, or Live Online

    Join us in an overview of the current state and future direction of transplant, cellular, and gene therapies. Gain insights into emerging clinical advances, evolving care delivery models, and opportunities to enhance patient access and outcomes.

    View course and register

    The Older Adult with Cancer: Personalizing Treatment Decisions

    Runs: October 16, 2026
    Course format: Online and In-Person (Philadelphia, PA)

    In conjunction with Penn Medicine’s Abramson Cancer Center and its Center for Cancer & Aging, Dana-Farber Cancer Institute presents this activity to discuss the latest advancements in personalized care and comprehensive assessments for older adults with cancer.

    View course and register

    Updates to Cancer Survivorship: Optimizing Care and Outcomes

    Available: until January 28, 2028
    Course format: Online; self-paced

    This course is designed to educate clinicians on the latest advancements in cancer survivorship care, focusing on evidence-based strategies to enhance patient outcomes and address the unique needs of diverse cancer survivors.

    View course and register

    Harvard Cancer Consortium Events and Resources

    Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Harvard Cancer Consortium (HCC), a Comprehensive Cancer Center designated by the National Cancer Institute.

    Explore HCC's calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.